Morphological and molecular pathology of lung cancer;Morphologische und molekulare Pathologie des Lungenkarzinoms

Pathologe

Volumn 31, Issue SUPPL. 2, 2010, Pages 204-210

  Petersen, I ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Aneuploidy; Classification; EGFR gene; KRAS gene; Lung cancer

Indexed keywords

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN; TUMOR MARKER;

ADENOCARCINOMA; CANCER INVASION; COOPERATION; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INTERDISCIPLINARY COMMUNICATION; LUNG; LUNG NON SMALL CELL CANCER; LUNG TUMOR; PATHOLOGY; PLOIDY; REVIEW; SMALL CELL CARCINOMA;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; COOPERATIVE BEHAVIOR; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERDISCIPLINARY COMMUNICATION; LUNG; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; PLOIDIES; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 79953196557     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-010-1371-5     Document Type: Article

References (30)

1. Barlesi F, Pinot D, LeGoffic A et al (2005) Positive thyroid transcription factor I strongly correlates with survival of patients with adenocarcinoma of the lung. Br J Cancer 93:450-452
2. Barr S, Thomson S, Buck E et al (2008) Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions. Clin Exp Metastasis 23:685-693
3. Director's Challenge Consortium for the Molecular Classification of Lung Adenocarcinoma, Shedden K, Taylor JM et al (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14:822-827
4. Garber ME, Troyanskaya OG, Schluens K et al (2001) Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A 98:13784-13789
5. Garraway LA, Sellers WR (2006) Lineage dependency and lineage-survival oncogenes in human cancer. Nat Rev Cancer 6:593-602
6. Gazdar AF (2009) Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors. Oncogene 28:S24-S31
7. Goeckenjan G, Sitter H, Thomas M et al (2010) Prävention, Diagnose, Therapie und Nachsorge des Lungenkarzinoms. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. Interdisziplinäre S3-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin und der Deutschen Krebsgesellschaft. Pneumologie 64 (Suppl 2):e1-e164
8. Junker K, Petersen I (2008) Kleinzelliges Lungenkarzinom: Pathologie und Molekularpathologie. Onkologe 14:762-773
9. Robert Koch-Institut (Hrsg) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland (GEKID) e.V. (Hrsg) (2010) Krebs in Deutschland 2005/2006. Häufigkeiten und Trends, 7. überarb. Aufl. Berlin. http://www.gekid.de
10. Kwei KA, Kim YH, Girard L et al (2008) Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer. Oncogene 27:3635-3640
11. Ladanyi M, Pao W (2008) Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond. Mod Pathol 21:516-522
12. Meyerson M, Franklin WA, Kelley MJ (2004) Molecular classification and molecular genetics of human lung cancers. Semin Oncol 31 (Suppl 1):4-19
13. Motoi N, Szoke J, Riely GJ et al (2008) Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol 32:810-827
14. Osada H, Tomida S, Yatabe Y et al (2008) Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancer. Cancer Res 68:1647-1655
15. Penzel R, Sers C, Chen Y et al (2010) EGFR mutation detection in NSCLC-assessment of diagnostic application and recommendations of the german panel for mutation testing in NSCLC. (Manuskript eingereicht)
16. Perner S, Wagner PL, Demichelis F et al (2008) EML4-ALK fusion lung cancer: a rare acquired event. Neoplasia 10:298-302
17. Petersen I, Kotb WF, Friedrich KH et al (2009) Core classification of lung cancer: correlating nuclear size and mitoses with ploidy and clinicopathological parameters. Lung Cancer 65:312-318
18. Petersen I (1999) Rudolf-Virchow Preis 1999. Genetik von Karzinomen des Respirationstraktes: Korrelation Genotyp-Phänotyp. Verh Dtsch Ges Pathol 83:195-204
19. Petersen I, Langreck H, Wolf G et al (1997) Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer 75:79-86
20. Reichel MB, Ohgaki H, Petersen I, Kleihues P (1994) p53 mutations in primary human lung tumors and their metastases. Mol Carcinog 9:105-109
21. Rodig SJ, Mino-Kenudson M, Dacic S et al (2009) Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the Western population. Clin Cancer Res 15:5216-5223
22. Sato M, Shames DS, Gazdar AF, Minna JD (2007) A translational view of the molecular pathogenesis of lung cancer. J Thorac Oncol 2:327-343
23. Schulze S, Petersen I (2010) Gender and ploidy in cancer survival. Cell Oncol (in press)
24. Speicher MR, Petersen S, Uhrig S et al (2000) Analysis of chromosomal alterations in non-small cell lung cancer by multiplex-FISH, comparative genomic hybridization, and multicolor bar coding. Lab Invest 80:1031-1041
25. Stolz A, Ertych N, Kienitz A et al (2010) The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells. Nat Cell Biol 12:492-499
26. Tanaka H, Yanagisawa K, Shinjo K et al (2007) Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1. Cancer Res 67:6007-6011
27. Travis WD, Brambilla E, Müller-Hermeling K, Harris CC (Hrsg) (2004) Tumours of the lung, pleura, thymus and heart-Pathology and genetics. IARC, Lyon
28. Travis WD, Brambilla E, Noguchi M et al (2010) IASLC/ATS/ERS international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (im Druck)
29. Weichert W, Schewe C, Denkert C et al (2009) Molecular HPV typing as a diagnostic tool to discriminate primary from metastatic squamous cell carcinoma of the lung. Am J Surg Pathol 33:513-520
30. Weir BA, Woo MS, Getz G et al (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450:893-898